Intravenous fat emulsions (IVFEs) provide essential fatty acids (EFAs) and are a dense source of energy in parenteral nutrition (PN). Parenterally administered lipid was introduced in the 17th century but plagued with side effects. The formulation of IVFEs later on made it a relatively safe component for administration to patients. Many ingredients are common to all IVFEs, yet the oil source(s) and its (their) percentage(s) makes them different from each other. The oil used dictates how IVFEs are metabolized and cleared from the body. The fatty acids (FAs) present in each type of oil provide unique beneficial and detrimental properties. This review provides an overview of IVFEs and discusses factors that would help clinicians choose the optimal product for their patients.
WretlindA. Development of fat emulsions. JPEN J Parenter Enteral Nutr. 1981;5(3):230-235.
5.
FerezouJBachAC. Structure and metabolic fate of triacylglycerol- and phospholipid-rich particles of commercial parenteral fat emulsions. Nutrition. 1999;15(1):44-50.
6.
LunnMFausnightT. Hypersensitivity to total parenteral nutrition fat-emulsion component in an egg-allergic child. Pediatrics. 2011;128(4):1025-1028.
7.
Chapter 729: Globule size distribution in lipid injectable emulsions. In: United States Pharmacopeia and National Formulary (USP 36-NF31). Rockville, MD: U.S. Pharmacopeia; 2012:321-323.
MayerKGrimmHGrimmingerFSeegerW. Parenteral nutrition with n-3 lipids in sepsis. Br J Nutr. 2002;87(suppl 1):S69-S75.
14.
WaitzbergDLBellinati-PiresRSalgadoMM. Effect of total parenteral nutrition with different lipid emulsions of human monocyte and neutrophil functions. Nutrition. 1997;13(2):128-132.
15.
FurukawaKYamamoriHTakagiK. Influences of soybean oil emulsion on stress response and cell-mediated immune function in moderately or severely stressed patients. Nutrition. 2002;18(3):235-240.
16.
IyerKRSpitzLClaytonP. BAPS prize lecture: new insight into mechanisms of parenteral nutrition–associated cholestasis: role of plant sterols. British Association of Paediatric Surgeons. J Pediatr Surg. 1998;33(1):1-6.
17.
SalenGAhrensEHGrundySM. Metabolism of β-sitosterol in man. J Clin Invest. 1970;49(5):952-967.
18.
LeesAMMokHYLeesRSMcCluskeyMAGrundySM. Plant sterols as cholesterol-lowering agents: clinical trials in patients with hypercholesterolemia and studies of sterol balance. Atherosclerosis. 1977;28(3):325-338.
19.
KakisGKuksisA. Effect of intravenous infusion of Intralipid, cholesterol, and plant sterols on hepatic cholesterogenesis. Can J Biochem Cell Biol. 1984;62(1):1-10.
20.
SheferSSalenGNguyenL. Competitive inhibition of bile acid synthesis by endogenous cholestanol and sitosterol in sitosterolemia with xanthomatosis: effect on cholesterol 7 alpha-hydroxylase. J Clin Invest. 1988;82(6):1833-1839.
21.
ClaytonPTWhitfieldPIyerK. The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition. 1998;14(1):158-164.
22.
SaviniSD’AscenzoRBiagettiC. The effect of 5 intravenous lipid emulsions on plasma phytosterols in preterm infants receiving parenteral nutrition: a randomized clinical trial. Am J Clin Nutr. 2013;98(2):312-318.
23.
CarterBATaylorOAPrendergastDR. Stigmasterol, a soy lipid–derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR. Pediatr Res. 2007;62(3):301-306.
24.
LizRPereiraDFHorstH. Protected effect of Esenbeckia leiocarpa upon the inflammatory response induced by carrageenan in a murine air pouch model. Int Immunopharmacol. 2011;11(12):1991-1999.
25.
LizRZanattaLdos ReisGO. Acute effect of β-sitosterol on calcium uptake mediates anti-inflammatory effect in murine activated neutrophils. J Pharm Pharmacol. 2013;65(1):115-122.
26.
ByrneWJ. Intralipid or Liposyn—comparable products?J Pediatr Gastroenterol Nutr. 1982;1(1):7-8.
27.
HolmanRTJohnsonSBHatchTF. A case of human linolenic acid deficiency involving neurological abnormalities. Am J Clin Nutr. 1982;35(3):617-623.
28.
UlrichHPastoresSMKatzDPKvetanV. Parenteral use of medium-chain triglycerides: a reappraisal. Nutrition. 1996;12(4):231-238.
29.
MokKTMaizAYamazakiK. Structured medium-chain and long-chain triglyceride emulsions are superior to physical mixtures in sparing body protein in the burned rat. Metabolism. 1984;33(10):910-915.
30.
DriscollDFNehneJPeterssHFrankeRBistrianBRNiemannW. The influence of medium-chain triglycerides on the stability of all-in-one formulations. Int J Pharm. 2002;240(1-2):1-10.
DeshpandeGCSimmerKMoriTCroftK. Parenteral lipid emulsions based on olive oil compared with soybean oil in preterm (<28 weeks’ gestation) neonates: a randomised controlled trial. J Pediatr Gastroenterol Nutr. 2009;49(5):619-625.
34.
WebbANHardyPPeterkinM. Tolerability and safety of olive oil–based lipid emulsion in critically ill neonates: a blinded randomized trial. Nutrition. 2008;24(11-12):1057-1064.
35.
RoggeroPMoscaFGiannìML. F2-isoprostanes and total radical-trapping antioxidant potential in preterm infants receiving parenteral lipid emulsions. Nutrition. 2010;26(5):551-555.
36.
DemirelGOguzSSCelikIHErdeveOUrasNDilmenU. The metabolic effects of two different lipid emulsions used in parenterally fed premature infants—a randomized comparative study. Early Hum Dev. 2012;88(7):499-501.
37.
van KempenAAMWvan der CrabbenSNAckermansMTEndertEKokJHSauerweinHP. Stimulation of gluconeogenesis by intravenous lipids in preterm infants: response depends on fatty acid profile. Am J Physiol Endocrinol Metab. 2006;290(4):E723-E730.
38.
KalishBTFallonEMPuderM. A tutorial on fatty acid biology. JPEN J Parenter Enteral Nutr. 2012;36(4):380-388.
39.
GaweckaAMichalkiewiczJKornackaMKLuckiewiczBKubiszewskaI. Immunologic properties differ in preterm infants fed olive oil vs soy-based lipid emulsions during parenteral nutrition. JPEN J Parenter Enteral Nutr. 2008;32(4):448-453.
40.
BagelSDessaigneBBourdeauxD. Influence of lipid type on bis (2-ethylhexyl)phthalate (DEHP) leaching from infusion line sets in parenteral nutrition. JPEN J Parenter Enteral Nutr. 2011;35(6):770-775.
41.
de MeijerVELeHDMeiselJAGuraKMPuderM. Parenteral fish oil as monotherapy prevents essential fatty acid deficiency in parenteral nutrition–dependent patients. J Pediatr Gastroenterol Nutr. 2010;50(2):212-218.
42.
GuraKMParsonsSKBechardLJ. Use of a fish oil–based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition. Clin Nutr. 2005;24(5):839-847.
RaptisDALimaniPJangJH. GPR120 on Kupffer cells mediates hepatoprotective effects of ω3-fatty acids. J Hepatol. 2014;60(3):625-632.
45.
KhanMZHeL. The role of polyunsaturated fatty acids and GPR40 receptor in brain [published online May22, 2015]. Neuropharmacology.
46.
Williams-BeyYBoularanCVuralA. Omega-3 free fatty acids suppress macrophage inflammasome activation by inhibiting NF-κB activation and enhancing autophagy. PLoS One. 2014;9(6):e97957.
47.
CornishJMacGibbonALinJ-M. Modulation of osteoclastogenesis by fatty acids. Endocrinology. 2008;149(11):5688-5695.
48.
de RoosBMavrommatisYBrouwerIA. Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease. Br J Pharmacol. 2009;158(2):413-428.
49.
SerhanCNChiangN. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br J Pharmacol. 2008;153(suppl):S200-S215.
50.
LeeSGuraKMKimSArsenaultDABistrianBRPuderM. Current clinical applications of omega-6 and omega-3 fatty acids. Nutr Clin Pract. 2006;21(4):323-341.
51.
VanekVWSeidnerDLAllenP. A.S.P.E.N. position paper: clinical role for alternative intravenous fat emulsions. Nutr Clin Pract. 2012;27(2):150-192.
52.
SiderovaVSCarpentierYADahlanWRichelleM. Intravascular metabolism of different fatty acids during lipid infusion in man. Clin Nutr. 1993;12(6):329-336.
53.
CorpeleijnWEVermeulenMJvan den AkkerCHvan GoudoeverJB. Feeding very-low-birth-weight infants: our aspirations versus the reality in practice. Ann Nutr Metab. 2011;58(suppl 1):20-29.
54.
QiKSeoTAl-HaideriM. Omega-3 triglycerides modify blood clearance and tissue targeting pathways of lipid emulsions. Biochemistry. 2002;41(9):3119-3127.
55.
BarnessL. Pediatric Nutrition Handbook. Elk Grove Village, IL: American Academy of Pediatrics; 2009.
56.
BrouwerCBde BruinTWJansenHErkelensDW. Different clearance of intravenously administered olive oil and soybean-oil emulsions: role of hepatic lipase. Am J Clin Nutr. 1993;57(4):533-539.
57.
HaumontDRichelleMDeckelbaumRJCoussaertECarpentierYA. Effect of liposomal content of lipid emulsions on plasma lipid concentrations in low birth weight infants receiving parenteral nutrition. J Pediatr. 1992;121(5, pt 1):759-763.
58.
HaumontDDeckelbaumRJRichelleM. Plasma lipid and plasma lipoprotein concentrations in low birth weight infants given parenteral nutrition with twenty or ten percent lipid emulsion. J Pediatr. 1989;115(5, pt 1):787-793.
59.
KalfarentzosFKokkinisKLeukaditiKMaroulisJOnoufriouAAlexopoulosK. Comparison between two fat emulsions: Intralipid 30 cent vs intralipid 10 cent in critically ill patients. Clin Nutr. 1998;17(1):31-34.
60.
SeidnerDLMascioliEAIstfanNW. Effects of long-chain triglyceride emulsions on reticuloendothelial system function in humans. JPEN J Parenter Enteral Nutr. 1989;13(6):614-619.
61.
NugentKM. Intralipid effects on reticuloendothelial function. J Leukoc Biol. 1984;36(2):123-132.
62.
RössleCCarpentierYARichelleM. Medium-chain triglycerides induce alterations in carnitine metabolism. Am J Physiol. 1990;258(6, pt 1):E944-E947.
63.
ReboucheCJPanagidesDDNelsonSE. Role of carnitine in utilization of dietary medium-chain triglycerides by term infants. Am J Clin Nutr. 1990;52(5):820-824.
64.
JohnsonRCYoungSKCotterRLinLRoweWB. Medium-chain-triglyceride lipid emulsion: metabolism and tissue distribution. Am J Clin Nutr. 1990;52(3):502-508.
65.
OliveiraFLRumseySCSchlotzerEHansenICarpentierYADeckelbaumRJ. Triglyceride hydrolysis of soy oil vs fish oil emulsions. JPEN J Parenter Enteral Nutr. 1997;21(4):224-229.
66.
NestelPJ. Effects of n-3 fatty acids on lipid metabolism. Annu Rev Nutr. 1990;10:149-167.
67.
RocheHMGibneyMJ. Long-chain n-3 polyunsaturated fatty acids and triacylglycerol metabolism in the postprandial state. Lipids. 1999;34(suppl):S259-S265.
68.
SpearMLStahlGEHamoshM. Effect of heparin dose and infusion rate on lipid clearance and bilirubin binding in premature infants receiving intravenous fat emulsions. J Pediatr. 1988;112(1):94-98.
69.
BerkowSESpearMLStahlGE. Total parenteral nutrition with Intralipid in premature infants receiving TPN with heparin: effect on plasma lipolytic enzymes, lipids, and glucose. J Pediatr Gastroenterol Nutr. 1987;6(4):581-588.
70.
KaoLCChengMHWarburtonD. Triglycerides, free fatty acids, free fatty acids/albumin molar ratio, and cholesterol levels in serum of neonates receiving long-term lipid infusions: controlled trial of continuous and intermittent regimens. J Pediatr. 1984;104(3):429-435.
71.
CarpentierYAHacquebardMPortoisLDupontIEDeckelbaumRJMalaisseWJ. Rapid cellular enrichment of eicosapentaenoate after a single intravenous injection of a novel medium-chain triacylglycerol:fish-oil emulsion in humans. Am J Clin Nutr. 2010;91(4):875-882.
72.
GervasioJ. Total nutrient admixtures (3-in-1): pros vs cons for adults. Nutr Clin Pract. 2015;30(3):331-335.
73.
BoullataJIGilbertKSacksG. A.S.P.E.N. clinical guidelines: parenteral nutrition ordering, order review, compounding, labeling, and dispensing. JPEN J Parenter Enteral Nutr. 2014;38(3):334-377.
74.
LeHDFallonEMKalishBT. The effect of varying ratios of docosahexaenoic acid and arachidonic acid in the prevention and reversal of biochemical essential fatty acid deficiency in a murine model. Metabolism. 2013;62(4):499-508.
FlemingCRSmithLMHodgesRE. Essential fatty acid deficiency in adults receiving total parenteral nutrition. Am J Clin Nutr. 1976;29(9):976-983.
77.
HolmanRT. The ratio of trienoic: tetraenoic acids in tissue lipids as a measure of essential fatty acid requirement. J Nutr. 1960;70:405-410.
78.
InnisSM. Essential fatty acids in infant nutrition: lessons and limitations from animal studies in relation to studies on infant fatty acid requirements. Am J Clin Nutr. 2000;71(1)(suppl):238S-244S.
79.
ReisbickSNeuringerMHasnainRConnorWE. Polydipsia in rhesus monkeys deficient in omega-3 fatty acids. Physiol Behav. 1990;47(2):315-323.
80.
ReisbickSNeuringerMHasnainRConnorWE. Home cage behavior of rhesus monkeys with long-term deficiency of omega-3 fatty acids. Physiol Behav. 1994;55(2):231-239.
81.
ConnorWE. Importance of n-3 fatty acids in health and disease. Am J Clin Nutr. 2000;71(1)(suppl):171S-175S.
82.
PeetMMurphyBShayJHorrobinD. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry. 1998;43(5):315-319.
83.
CalderPCJensenGLKoletzkoBVSingerPWantenGJA. Lipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directions. Intensive Care Med. 2010;36(5):735-749.
84.
GuraKMLeeSValimC. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition–associated liver disease. Pediatrics. 2008;121(3):e678-e686.
85.
Critical Care Nutrition. Canadian Clinical Practice Guidelines 10.2: Strategies to Optimize Parenteral Nutrition and Minimize Risks: Use of Lipids. 2013. www.criticalcarenutrition.com. Accessed April 14, 2016.
86.
EdmundsCEBrodyRAParrottJSStankorbSMHeylandDK. The effects of different IV fat emulsions on clinical outcomes in critically ill patients. Crit Care Med. 2014;42(5):1168-1177.
87.
McClaveSATaylorBEMartindaleRG. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2016;40(2):159-211.
88.
SingerPBergerMMVan den BergheG. ESPEN guidelines on parenteral nutrition: intensive care. Clin Nutr. 2009;28(4):387-400.
89.
Critical Care Nutrition. Canadian Clinical Practice Guidelines 9.2 Composition of Parenteral Nutrition: Type of Lipids. 2013. www.criticalcarenutrition.com. Accessed April 14, 2016.
90.
ManzanaresWLangloisPLHeylandDK. The role of alternative lipid emulsions in critically ill patients: what the evidence shows. JPEN J Parenter Enteral Nutr. 2014;38(6):653-654.
91.
ManzanaresWLangloisPLDhaliwalRLemieuxMHeylandDK. Intravenous fish oil lipid emulsions in critically ill patients: an updated systematic review and meta-analysis. Crit Care. 2015;19:167.
92.
KapoorVGloverRMalviyaMN. Alternative lipid emulsions versus pure soy oil based lipid emulsions for parenterally fed preterm infants. Cochrane Database Syst Rev. 2015;(12):CD009172.
93.
WalesPWAllenNWorthingtonP. A.S.P.E.N. clinical guidelines: support of pediatric patients with intestinal failure at risk of parenteral nutrition–associated liver disease. JPEN J Parenter Enteral Nutr. 2014;38(5):538-557.
94.
GouletOGirotRMaier-RedelspergerMBougleDVirelizierJRicourC. Hematologic disorders following prolonged use of intravenous fat emulsions in children. JPEN J Parenter Enteral Nutr. 1986;10(3):284-288.
95.
KesslerUZachariouZRazDPoeschlJLinderkampO. Effects of Intralipid infusion on hemorheology and peripheral resistance in neonates and children. Pediatr Surg Int. 2005;21(3):197-202.
96.
BransYWDuttonEBAndrewDSMenchacaEMWestDL. Fat emulsion tolerance in very low birth weight neonates: effect on diffusion of oxygen in the lungs and on blood pH. Pediatrics. 1986;78(1):79-84.
97.
SosenkoIRRodriguez-PierceMBancalariE. Effect of early initiation of intravenous lipid administration on the incidence and severity of chronic lung disease in premature infants. J Pediatr. 1993;123(6):975-982.
98.
PaolissoGManzellaDRizzoMR. Elevated plasma fatty acid concentrations stimulate the cardiac autonomic nervous system in healthy subjects. Am J Clin Nutr. 2000;72(3):723-730.
99.
MathruMDriesDJZeccaAFareedJRooneyMWRaoTL. Effect of fast vs slow Intralipid infusion on gas exchange, pulmonary hemodynamics, and prostaglandin metabolism. Chest. 1991;99(2):426-429.
100.
HayesBDGosselinSCalelloDP. Systematic review of clinical adverse events reported after acute intravenous lipid emulsion administration. Clin Toxicol (Phila). 2016;54(5):1-40.
101.
KoletzkoBGouletOHuntJKrohnKShamirR. 1. Guidelines on paediatric parenteral nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), supported by the European Society of Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr. 2005;41(suppl 2):S1-S87.
102.
KollefMHMcCormackMTCarasWEReddyVVBaconD. The fat overload syndrome: successful treatment with plasma exchange. Ann Intern Med. 1990;112(7):545-546.
103.
HeymanMBStorchSAmentME. The fat overload syndrome: report of a case and literature review. Am J Dis Child. 1981;135(7):628-630.
104.
BurckartGJWhitingtonPFHalbrehderDKHelmsRA. Triglyceride and fatty acid clearance in neonates following safflower oil emulsion infusion. JPEN J Parenter Enteral Nutr. 1983;7(3):251-253.
105.
GuraKMPuderM. Rapid infusion of fish oil–based emulsion in infants does not appear to be associated with fat overload syndrome. Nutr Clin Pract. 2010;25(4):399-402.
106.
TonMNChangCCarpentierYADeckelbaumRJ. In vivo and in vitro properties of an intravenous lipid emulsion containing only medium chain and fish oil triglycerides. Clin Nutr. 2005;24(4):492-501.
HojsakIKolacekS. Fat overload syndrome after the rapid infusion of SMOFlipid emulsion. JPEN J Parenter Enteral Nutr. 2014;38(1):119-121.
109.
AngelicoMDella GuardiaP. Review article: hepatobiliary complications associated with total parenteral nutrition. Aliment Pharmacol Ther. 2000;14(suppl 2):54-57.
110.
KumpfVJ. Parenteral nutrition–associated liver disease in adult and pediatric patients. Nutr Clin Pract. 2006;21(3):279-290.
111.
BeathS VDaviesPPapadopoulouA. Parenteral nutrition–related cholestasis in postsurgical neonates: multivariate analysis of risk factors. J Pediatr Surg. 1996;31(4):604-606.
112.
NandivadaPCowanECarlsonSJChangMGuraKMPuderM. Mechanisms for the effects of fish oil lipid emulsions in the management of parenteral nutrition–associated liver disease. Prostaglandins Leukot Essent Fat Acids. 2013;89(4):153-158.
113.
AlwaynIPJGuraKNoséV. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr Res. 2005;57(3):445-452.
114.
GuraKMDugganCPCollierSB. Reversal of parenteral nutrition–associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics. 2006;118(1):e197-e201.
115.
LamHSTamYHPoonTCW. A double-blind randomised controlled trial of fish oil–based versus soy-based lipid preparations in the treatment of infants with parenteral nutrition–associated cholestasis. Neonatology. 2014;105(4):290-296.
116.
NandivadaPFellGLMitchellPD. Long-term fish oil lipid emulsion use in children with intestinal failure-associated liver disease [published online March9, 2016]. JPEN J Parenter Enteral Nutr.
117.
GuptaKWangHAminSB. Parenteral nutrition–associated cholestasis in premature infants: role of macronutrients. JPEN J Parenter Enteral Nutr. 2016;40(3):335-341.
118.
CoberMPKilluGBrattainAWelchKBKunisakiSMTeitelbaumDH. Intravenous fat emulsions reduction for patients with parenteral nutrition–associated liver disease. J Pediatr. 2012;160(3):421-427.
119.
RollinsMDWardRMJacksonWD. Effect of decreased parenteral soybean lipid emulsion on hepatic function in infants at risk for parenteral nutrition–associated liver disease: a pilot study. J Pediatr Surg. 2013;48(6):1348-1356.
120.
SanchezSEBraunLPMercerLDSherrillMStevensJJavidPJ. The effect of lipid restriction on the prevention of parenteral nutrition–associated cholestasis in surgical infants. J Pediatr Surg. 2013;48(3):573-578.
121.
LevitOLCalkinsKLGibsonLC. Low-dose intravenous soybean oil emulsion for prevention of cholestasis in preterm neonates. JPEN J Parenter Enteral Nutr. 2016;40(3):374-382.
122.
DiamondIRSterescuAPencharzPBKimJHWalesPW. Changing the paradigm: Omegaven for the treatment of liver failure in pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr. 2009;48(2):209-215.
123.
MuhammedRBremnerRProtheroeSJohnsonTHoldenCMurphyMS. Resolution of parenteral nutrition–associated jaundice on changing from a soybean oil emulsion to a complex mixed-lipid emulsion. J Pediatr Gastroenterol Nutr. 2012;54(6):797-802.
124.
AttardMPatelNSimpsonJ. Change from Intralipid to SMOF lipid is associated with improved liver function in infants with PN associated liver disease. Arch Dis Child. 2012;97(suppl 1):A54-A55.
125.
VanekVWSeidnerDLAllenP. A.S.P.E.N. position paper: clinical role for alternative intravenous fat emulsions. Nutr Clin Pract. 2012;27(2):150-192.
126.
NijveldtRJTanAMPrinsHA. Use of a mixture of medium-chain triglycerides and long-chain triglycerides versus long-chain triglycerides in critically ill surgical patients: a randomized prospective double-blind study. Clin Nutr. 1998;17(1):23-29.
127.
LindgrenBFRuokonenEMagnusson-BorgKTakalaJ. Nitrogen sparing effect of structured triglycerides containing both medium-and long-chain fatty acids in critically ill patients: a double blind randomized controlled trial. Clin Nutr. 2001;20(1):43-48.
128.
Garnacho-MonteroJOrtiz-LeybaCJiménez-JiménezFJ. Clinical and metabolic effects of two lipid emulsions on the parenteral nutrition of septic patients. Nutrition. 2002;18(2):134-138.
129.
GrecuIMireaLGrintescuI. Parenteral fish oil supplementation in patients with abdominal sepsis. Clin Nutr. 2003;22:S23.
130.
HuschakGZur NiedenKHoellTRiemannDMastHStuttmannR. Olive oil based nutrition in multiple trauma patients: a pilot study. Intensive Care Med. 2005;31(9):1202-1208.
131.
IovinelliGMarinangeliFCicconeA. Parenteral nutrition in ventilated patients with chronic obstructive pulmonary disease: long chain vs medium chain triglycerides. Minerva Anestesiol. 2007;73 (1-2):65-76.
132.
García-de-LorenzoADeniaRAtlanP. Parenteral nutrition providing a restricted amount of linoleic acid in severely burned patients: a randomised double-blind study of an olive oil–based lipid emulsion v. medium/long-chain triacylglycerols. Br J Nutr. 2005;94(2):221-230.
133.
FrieseckeSLotzeCKöhlerJHeinrichAFelixSBAbelP. Fish oil supplementation in the parenteral nutrition of critically ill medical patients: a randomised controlled trial. Intensive Care Med. 2008;34(8):1411-1420.
134.
WangXLiWZhangFPanLLiNLiJ. Fish oil–supplemented parenteral nutrition in severe acute pancreatitis patients and effects on immune function and infectious risk: a randomized controlled trial. Inflammation. 2009;32(5):304-309.
135.
BarbosaVMMilesEACalhauCLafuenteECalderPC. Effects of a fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: a randomized, controlled clinical trial. Crit Care. 2010;14(1):R5.
136.
UmpierrezGESpiegelmanRZhaoV. A double-blind, randomized clinical trial comparing soybean oil–based versus olive oil–based lipid emulsions in adult medical-surgical intensive care unit patients requiring parenteral nutrition. Crit Care Med. 2012;40(6):1792-1798.
137.
Pontes-ArrudaADos SantosMCFCMartinsLF. Influence of parenteral nutrition delivery system on the development of bloodstream infections in critically ill patients: an international, multicenter, prospective, open-label, controlled study—EPICOS study. JPEN J Parenter Enteral Nutr. 2012;36(5):574-586.
